Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Endometriosis

Endometriosis

Subtypes of Endometriosis

Deep infiltrating endometriosis 1 Diaphragmatic Endometriosis 1 Ovarian endometriosis cyst 1

14 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Endometriosis

46 trials tracked for Endometriosis: 15 in phase 3 or 4 and 12 with published results. The most-cited published study has 539 citations.

46Trials tracked
15Phase 3 & 4
0Recruiting
12With published results
Phase distribution
Phase 4 6 Phase 3 9 Phase 2 18 Phase 1 1 Other / NA 12
  1. Phase 4 Resveratrol for Pain Due to Endometriosis Completed · 539 cited
  2. Phase 3 A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Completed · 491 cited
  3. Phase 3 A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Completed · 489 cited
  4. Phase 3 SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain Completed · 50 cited
  5. Phase 3 Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain. Completed · 38 cited
  6. Phase 3 A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain Completed · 36 cited
Show 40 more trials
  1. Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain Completed · 31 cited
  2. Phase 3 Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain Completed · 27 cited
  3. Phase 4 Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF Completed · 19 cited
  4. Phase 4 Chronic Pain Risk Associated With Menstrual Period Pain Completed · 8 cited
  5. Phase 3 Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis Completed · 6 cited
  6. Phase 3 Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6) Completed · 1 cited
  7. Phase 4 Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Completed
  8. Phase 4 Ulipristal for Endometriosis-related Pelvic Pain Completed
  9. Phase 4 The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis. Completed
  10. Phase 2 Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI Completed
  11. Phase 2 Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis Completed
  12. Phase 2 A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers Completed
  13. Phase 2 A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis Completed
  14. Phase 2 Bay98-7196, Dose Finding / POC Study Completed
  15. Phase 2 Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study Completed
  16. Phase 2 Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis Completed
  17. Phase 2 A Study to Assess the Efficacy and Safety of HMI-115 in Subjects With Endometriosis-Associated Pain Completed
  18. Phase 2 BGS649 Monotherapy in Moderate to Severe Endometriosis Patients Completed
  19. Phase 2 Botulinum Toxin for Pelvic Pain in Women With Endometriosis Completed
  20. Phase 2 The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial Completed
  21. Phase 2 A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain Completed
  22. Phase 2 Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis Completed
  23. Phase 2 Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis Completed
  24. Phase 2 Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirmed, Symptomatic Endometriosis Completed
  25. Phase 2 Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of Endometriomas Completed
  26. Phase 2 Elagolix for Fertility Enhancement Clinical Trial Completed
  27. Phase 2 Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Completed
  28. Phase 1 A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects Completed
  29. N/A A Survey on Efficacy and Safety in Patients With Endometriosis Completed
  30. N/A Endometriosis Group Care Completed
  31. N/A Dyspareunia and Central Sensitization Completed
  32. N/A An AHEI Dietary Intervention to Reduce Pain in Women With Endometriosis Completed
  33. N/A GnRH-a and Pregnancy Rate in In Vitro Fertilization (IVF) Cycles. Completed
  34. N/A Enriched Environments in Endometriosis Completed
  35. N/A Novel Web-based, Self-directed Intervention for Chronic Pelvic Pain Completed
  36. N/A The Association Between Endometriosis, Obesity and nesfatin1 Completed
  37. N/A Ultravision™ System to Facilitate Low Impact Laparoscopic Surgery for Endometriosis Completed
  38. N/A Effects of Intravenous Lidocaine on Endometriosis Pain Completed
  39. N/A Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a Prospective Randomized Controlled Trial Completed
  40. N/A A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laparoscopy to Detect Endometriosis Completed

Showing the 46 most-cited and recently-updated of 46 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Mendelian randomization links genetic endometriosis liability to increased placenta praevia risk
OB/GYN & Women's Health Meta-analysis
Mendelian randomization links genetic endometriosis liability to increased placenta praevia risk Does endometriosis raise pregnancy risks? A genetic link points to one specific danger
A Mendelian randomization meta-analysis using summary-level GWAS data found genetic liability to endometriosis was robustly associated with …
A woman's genetic risk for endometriosis directly increases the chance of placenta praevia, a dangerous condition where the placenta grows t…
medRxiv Apr 8, 2026
Qualitative study reveals divergent perceptions of hormonal therapy efficacy in endometriosis management
OB/GYN & Women's Health
Qualitative study reveals divergent perceptions of hormonal therapy efficacy in endometriosis management Endometriosis patients and doctors often disagree on what makes treatment effective
A qualitative study of 20 endometriosis patients and 13 healthcare professionals found divergent perceptions of hormonal treatment efficacy.
Endometriosis patients seek pain relief while doctors prioritize stopping periods, creating a communication gap that adds mental burden to b…
medRxiv Apr 8, 2026

Questions about Endometriosis

Does exposure to BPA increase my risk of developing endometriosis based on recent studies?

Yes, recent meta-analyses show BPA exposure is linked to a higher risk of endometriosis, with odds ratios of 1.36 and 1.82.

Full answer →